FACTORS RELATED TO HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH GRAVES' DISEASE
Main Article Content
Abstract
Objective: Identify some factors related to the quality of life of children with Graves’
disease.
Subject and method: A cross-sectional descriptive study, total of 80 children with Basedow
from 8 to 18 years old were diagnosed, treated and monitored at the National Hospital of
Endocrinology from July 2020 to June 2021, and were assessed the health-related quality of
life by the scale PedsQLTM 4.0.
Results: Assessing self-reported health-related quality of life scores by children with Graves’
disease (8-18 years old) in the areas of physical, emotional, social relationships, learning and
general quality of life using the PedsQLTM 4.0 scale and find the relationship between quality
of life scores related to health and a number of factors such as: age, sex, time of disease
follow-up and disease manifestations. Research results show that a number of factors that
reduce the quality of life related to the health of children with Graves disease include: age
group from 13-18 years old, children with Graves’ disease are male, have a long follow-up
time for the disease longer than 24 months and children showed protrusion compared with
the control group.
Conclusion: Some factors that reduce health-related quality of life in children with Graves’
disease such as: older children age, male gender, prolonged follow-up time, and children
with Graves’ disease have protruding eyes.
Article Details
Keywords
Quality of life, children, Graves’ disease, PedsQLTM 4.0.
References
Guidelines for the treatment of childhoodonset Graves’ disease in Japan. Clinical
Pediatric Endocrinology: Case reports and
clinical investigations: Official Journal of the
Japanese Society for Pediatric Endocrinology,
2017;26(2):29-62.
[2] Varni JW, Seid M, Kurtin PS, PedsQL
4.0: reliability and validity of the Pediatric
Quality of Life Inventory version 4.0 generic
core scales in healthy and patient populations.
Medical Care, 2001;39(8):800-812.
[3] Mai NT, Net TT, Huyen VP, Healthrelated quality of life survey in children
by PedsQLTM 4.0 generic core scale,
Vienamese Version, Journal of Practical
medicine, 2017;1045(6):183-193.
[4] Lane LC, Rankin J, Cheetham T, A survey
of the young person’s experience of Graves’91
disease and its management. Clinical
Endocrinology, 2021, 94(2): 330–340.
[5] Riguetto CM, Neto AM, Tambascia MA et
al., The relationship between quality of life,
cognition, and thyroid status in Graves’
disease, Endocrine, 2018, 63(1): 87–93.
[6] Delfino LC, Zunino A, Sapia V et al., Related
quality of life questionnaire specific to
dysthyroid ophthalmopathy evaluated in a
population of patients with Graves’ disease.
Archives of Endocrinology and Metabolism,
2017; 61(4):374-381.
[7] Taylor PN, Zhang L, Lee RW et al.,
New insights into the pathogenesis
and nonsurgical management of
Graves orbitopathy, Nature Reviews
Endocrinology, 2020;16(2):104-116.
[8] Yousef A, Devereux M, Gourraud PA et
al., Subclinical saccadic eye movement
dysfunction in pediatric multiple sclerosis.
Journal of Child Neurology, 2018;
34(1):38-43.